로딩 중…
지수 로딩 중…
Nkarta, Inc.
NKTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.86+8.33%
2026-06-18
Price Chart
Nkarta, Inc.+57.14%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $205M |
| Revenue | $0.00 |
| Net Income | $-100M |
| Total Assets | $372M |
| Net Assets | $286M |
| Value | |
| P/B | 0.72x |
| FCF Yield | -43.20% |
| Profitability | |
| ROE | -34.96% |
| ROA | -26.86% |
| Financial Health | |
| Debt Ratio | 30.16% |
| Total Debt | $75M |
| FCF | $-88M |
| Cash | $27M |
| Current Ratio | 12.96x |
| Performance | |
| 1Y Return | 57.14% |
| 1M Return | 6.72% |
| From 52W High | -21.64% |
| 1Y MDD | -34.22% |
| Trading | |
| Volume | 555,122 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-1.04 |
| BPS | $4.56 |